MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Triple Helix Framework
Industry
Architects: Small & Medium Size Business (SMBs), Product Development, De-Risking, Validation, Building Niche & Emerging Markets
*Architects: Ophthalmology, Optometry & Ocular Health (BioPharmaceuticals & Biotechnology)
AXIM Biotechnologies (OTCQB:AXIM)
Organization & Developments: Axim Biotechnologies
Parents
AXIM Biotechnologies (OTCQB:AXIM)
Children
*Developed a tear drop test that is the first rapid, non-invasive, point-of-care diagnostic for Parkinson’s disease (PD). The test detects abnormal alpha-synuclein—an important emerging biomarker of PD—found in a person’s tears.
2017: AXIM Biotechnologies' Recent Patent Does Not Offer Value To Investors - Axim Biotechnologies, Inc. (OTCMKTS:AXIM)
2023: Tear Drop Test Is First Rapid, Point-of-Care Diagnostic for Parkinson’s Disease
Jumps
Finance & Acquisitions: Axim Biotechnologies
Key People: Axim Biotechnologies